Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-29 @ 6:09 AM
Study NCT ID:
NCT02778204
Status:
COMPLETED
Last Update Posted:
2022-01-04
First Post:
2016-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-13
First Submit QC Date:
None
Study First Post Date:
2016-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-02
Results First Submit QC Date:
None
Results First Post Date:
2020-11-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-30
Last Update Post Date:
2022-01-04
Last Update Post Date Type:
ACTUAL